Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
September 25, 2025 Off

Zealand Pharma appoints Rachel James-Owens as Vice President, Corporate Communications & Media Relations

By GlobeNewswire

Press release – No. 14 / 2025 Zealand Pharma appoints Rachel James-Owens as Vice President, Corporate Communications & Media Relations…

September 24, 2025 Off

Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

By GlobeNewswire

CHASKA, Minn., Sept. 23, 2025 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and…

September 24, 2025 Off

Biogen Provides Regulatory Update on High Dose Regimen of Nusinersen

By GlobeNewswire

CAMBRIDGE, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug…

September 24, 2025 Off

Natural Alternatives International, Inc. Announces Fiscal 2025 Q4 and YTD Results

By GlobeNewswire

CARLSBAD, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) — Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII), a leading formulator, manufacturer, and…

September 24, 2025 Off

OSE Immunotherapeutics acknowledges the decision of the Nantes Commercial Court

By GlobeNewswire

OSE Immunotherapeutics acknowledges the decision of the Nantes Commercial Court NANTES, France – September 23, 2025, 10:30 p.m. CET –…

September 24, 2025 Off

Aardvark Therapeutics to Present at the Stifel 2025 Virtual Cardiometabolic Forum

By GlobeNewswire

SAN DIEGO, Sept. 23, 2025 (GLOBE NEWSWIRE) — Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on…

September 24, 2025 Off

Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology (UEG) Meeting

By GlobeNewswire

Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology…

September 24, 2025 Off

Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company

By GlobeNewswire

– Cyclerion Relaunches, Advancing a Phase 2–Ready Program for Millions Living with Treatment-Resistant Depression Through MIT License Agreement – – Webcast to be…

September 24, 2025 Off

Supplements For Testosterone Booster 2025: TestoPrime” Natural Testosterone Booster Supplement For Men 40 or 50 launch in USA.

By GlobeNewswire

TestoPrime launch a Effective and Best Testosterone Booster Supplement For Men 40 or 50, this is most popular and natural…

September 24, 2025 Off

IPSEN – Buy-back programme – Art 5 of MAR – Week 38 – 2025

By GlobeNewswire

Aggregated presentation by day and by marketStatement of transactions in own shares from September 15th to September 19th 2025       Name of…

Posts pagination

Previous 1 … 79 80 81 … 3,605 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine